Matt Wilson, epidemiologist at UKHSA

Matt Wilson: key facts

Kind of voice: Academic
Role: epidemiologist at UKHSA
Quoted on: Respiratory (asthma/COPD)
Tracked press citations: 1
Most recently quoted: 10 Sept 2026

“Our evaluation of the first season of the programme in England gives important confirmation that maternal RSV vaccination is highly protective for newborn infants, over 80%, and that effectiveness reached nearly 85% when vaccination occurred at least four weeks before birth.”
on Respiratory (asthma/COPD) · 10 Sept 2026 · Read the article ↗

Where Matt Wilson has been quoted

RSV maternal vaccine cuts baby hospital admissions by up to 85%pulsetoday.co.uk · 10 Sept 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Household e-cigarette exposure linked to poorer asthma control in childrenContemporary Pediatrics
AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trialsPharmafile
Lung cancer is India’s deadliest cancer. So why don’t we screen for it?The Indian Express

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.